Ascension St. John Hospital Hematology Oncology Fellowship
Ascension St. John Hospital Hematology and Oncology Subspecialty Fellowship Training Program is a three year combined Hematology and Oncology Program targeting two qualified candidates each year.
The training program comprises of 13 months of in-hospital clinical rotations, 11 months of elective/clinical rotations, and 12 months of basic or clinical research experience, continuity clinics and planned didactic conferences and lectures throughout the 3-year program.
Each Hematology Oncology Fellow receives support to attend one professional meeting each year such as the American Society of Hematology or American Society or Clinical Oncology.
Each fellow is nominated for professional membership in these Societies.
Zyad Kafri, MD, MS, FACP
Assistant Professor of Medicine, WSU
Daniel Lebovic, MD
Chief of Hematology/Oncology Department
Tarik Hadid, MD, MS, FACP
Assistant Professor of Medicine, WSU
Carrie Dul, MD
Lokesh Nagori, MD
Training is divided as follows
- Hematology 6 months
- Oncology 6 months
- Bone Marrow Transplant 1 month
- General Hematology/Oncology Continuity Clinic 1/2 day weekly for 36 months
- Specialty Clinic Breast 2 months
- Specialty Clinic Hematology 2 months
- Ambulatory Oncology/Genetics 2 months
- Lab Medicine/Apheresis 1 month
- GYN Oncology 1 month
- Pediatric Hematology/Oncology 1 month
- Radiation Oncology 1 month
Scholarly Activity 12 months
The inpatient Oncology and the inpatient Hematology Academic Services provide consultations on patients with cancer or blood disorders who are hospitalized in Ascension St. John Hospital. In addition, these services provide care for patients admitted to the Oncology or Hematology Academic Inpatient services. The assigned Fellow is responsible for evaluating the patient’s history, clinical and laboratory findings and using these to make recommendations for further diagnostic evaluations, treatment and monitoring of response. The treatment plan should include management of the cancer and its related symptoms, taking into consideration co-existing clinical conditions. The Hematology-Oncology Fellow will present the data to the attending physician on the Hematology or Oncology service and will prepare the official written interpretation and recommendations for the referring physician. The Fellow will also continue to follow the patient and write notes when ongoing participation in the clinical care of the patient is warranted. The Fellow will also work with the palliative care nurse practitioner who participates on the inpatient team to integrate aspects of palliative care into the patient’s treatment plan as appropriate.
Fellows will have one-half day per week in General Hematology/Oncology Continuity Clinic for the duration of their training. They will also participate in subspecialty clinic experiences in Breast Cancer, Hematology. Outpatient care electives include Ambulatory Oncology/Genetics, Lab Medicine/Apheresis, GYN Oncology, Pediatric Hematology/Oncology and Radiation Oncology.
Stem Cell Transplant/Malignant Hematology
Fellows rotating on the in-patient unit will experience two months rotation at Henry Ford Hospital one month for BMT. Fellows will experience a comprehensive in-depth exposure to the acute management of patients with hematologic and non-hematologic malignancies who are undergoing autologous or allogeneic transplantation, and patients who are undergoing salvage chemotherapy prior to initiation of the transplant maneuver. In addition to one dedicated month for Ambulatory malignant hematology, will be familiar with the diagnosis and management of hematologic malignancies.
There are multiple research opportunities both within the Department of Hematology and Oncology and within other departments. Fellows will have 12 months during their fellowship that they can devote to research. They will maintain one-half day of continuity clinic, and add another one-half day clinic of their choice and focus of interest during their research year. The majority of their remaining time is dedicated to research. The projects can be clinical, epidemiological, health policy, translational, basic or other areas if it is of significant educational value for research training in Hematology and Oncology.
We accept applications only through ERAS. Interviews will take place in September and October.
2018 Uqba Khan,MD-Dr. Khan graduated in June 2018. He joined Weill Cornell as a Junior Faculty Member in the GI department. Starting in July 2019 Dr. Khan will continue as an Assistant Professor at Weill Cornell Medical College.
"My stay at St. John was one of the most important and rewarding time of my medical training. Though, I was a little uncertain about my career when I joined fellowship program considering I would be the first graduating fellow of this new program, however i was pleasantly surprised by my experience, and type of attention and close mentoring that I received by both faculty as well as the supporting staff. Although every individual of the fellowship program helped me grow during my fellowship I would like to point out Dr. Kafri as the key person in mentoring and teaching me not only the medical aspect of oncology but also humane and ethical aspect of medicine as well. I think he is truly a great physician and even a better mentor and teacher. He sincerely works for the betterment of the program and invests his precious time to build careers of his fellows. It is an amazing task to build a new program from scratch and bring it to such a level that is attracting such wonderful candidates for future fellowship positions. Now it has been two weeks since I started working at Weill Cornell, and I have already experienced the dividends of my training at St. John. I feel like I am ready and confident for real world oncology practice. My new mentor and colleagues are already impressed by my work and knowledge at Weill Cornell. I think it is due to the exceptional leadership of Dr. Kafri and his awesome team. In a nutshell, I would recommend this program without any hesitation to anybody who is interested in learning the science and art of practicing Hematology/Oncology" Uqba Khan, MD July 2018
2018 Dahlia Sano,MD-Dr. Sano graduated in June 2018 and went on to further her education in Lymphoma at MD Anderson Cancer Center in Houston, TX. In August 2019 Dr. Sano will be joining the Lymphoma Department at Karmanos Cancer Center as an Assistant Professor for Wayne State University.
"Starting as the first batch in a new program was intimidating but also challenging. On the first day I felt that I am in a different world that speaks a different language. i still can't believe that, by the end of the first year I was sitting comfortably in tumor boards giving my opinion about the cases presented. The energy, the enthusiasm and team spirit in my program, pushed me to give my best and be my best. It was an enjoyable journey. We came across challenges but we got stronger going through them. I thank my program and everyone that worked with me to be a better Hematology/Oncologist. My plan is to pursue further education in Lymphoma at MD Anderson Cancer Center. After that I plan to join an academic institution to be part of educating fellows and residents." Dahlia Sano, MD June 2018